Coronavirus Update: Moderna Still Confident Of November Readout

Neck And Neck With Pfizer

The company said its own calculations suggested a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.  

Paris 16 10 2020 Europe Under Lockdown
Paris, France: President Macron has imposed a new lockdown on the country, to last until at least the end of November. Like much of Europe, France is experiencing rapidly rising infection rates.

Moderna is confident that its COVID-19 vaccine candidate mRNA-1273 is on track to report early data by mid-November, which could set up an emergency use authorization if the data are encouraging.

The company’s CEO Stéphane Bancel offered the reassurance during the company’s Q3 results call on 29 October, and said it...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from COVID-19

More from Scrip